Goldman Sachs’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $72M | Buy |
|
|||||
|
2021
Q2 | $14.7M | Sell |
|
|||||
|
2021
Q1 | $48.4M | Buy |
|
|||||
|
2020
Q4 | $40.6M | Sell |
|
|||||
|
2020
Q3 | $54.1M | Sell |
|
|||||
|
2020
Q2 | $47M | Buy |
|
|||||
|
2020
Q1 | $39M | Buy |
|
|||||
|
2019
Q4 | $17M | Sell |
|
|||||
|
2019
Q3 | $15.7M | Sell |
|
|||||
|
2019
Q2 | $17.7M | Sell |
|
|||||
|
2019
Q1 | $21.5M | Buy |
|
|||||
|
2018
Q4 | $11.2M | Sell |
|
|||||
|
2018
Q3 | $26.3M | Sell |
|
|||||
|
2018
Q2 | $26.2M | Sell |
|
|||||
|
2018
Q1 | $21.7M | Sell |
|
|||||
|
2017
Q4 | $25.9M | Sell |
|
|||||
|
2017
Q3 | $23.6M | Buy |
|
|||||
|
2017
Q2 | $15.8M | Buy |
|
|||||
|
2017
Q1 | $13.3M | Buy |
|
|||||
|
2016
Q4 | $12.1M | Sell |
|
|||||
|
2016
Q3 | $30.2M | Buy |
|
|||||
|
2016
Q2 | $14.2M | Buy |
|
|||||
|
2016
Q1 | $5.74M | Buy |
|
|||||
|
2015
Q4 | $799K | Buy |
|
|||||
|
2015
Q3 | $245K | Sell |
|
|||||
|
2015
Q2 | $906K | Buy |
|
|||||
|
2015
Q1 | $428K | Sell |
|
|||||
|
2014
Q4 | $639K | Buy |
|